Medicines for external use in the treatment of hyperosteogeny

Abstract

The invention relates to the field of traditional Chinese medicinal formulations, particularly relates to an externally-applied medicinal preparation for treating hyperosteogeny, which is characterized in that the externally-applied medicinal preparation is prepared from the following raw materials in parts by weight: Rhododendron molle 15-20 parts, Pyrola rotundifolia 10-15 parts, Carthamus tinctorius flower 8-12 parts, Datura metel flower 10-12 parts, Pheretima 10-15 parts, Daemonorops draco 6-10 parts, Ligusticum chuanxiong 20-25 parts, Drynaria fortunei 6-8 parts, Impatiens balsamina 10-12 parts, Pittosporum tobira bark 12-15 parts, Chaenomeles speciosa fruit 15-20 parts, Eucommia ulmoides 8-10 parts, Hedera sinensis 12-16 parts, Spatholobus suberectus stem 6-10 parts, Angelica sinensis 15-20 parts, Curcuma longa 16-18 parts, Radix Paeoniae Rubra (Paeonia lactiflora and / or Paeonia veitchii) 12-16 parts, Moschus 3-5 parts, and camphor 3-5 parts by pulverizing the above raw materials into fine powder. The externally-applied medicinal preparation of the invention has low cost, high efficacy in treatment of hyperosteogeny, no toxic or side effect, and has effects of relieving exterior syndrome, dispelling cold, expelling wind and removing dampness, dredging blood stasis, smoothing collaterals, eliminating oppression of hyperosteogeny to nerve root, rapidly relieving pain and relieving numbness, repairing nerve atrophy and dissolving prominent hyperosteogeny neoplasms, so as to solve the problem from the source.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to an external medicine for treating hyperosteogeny. Background technique [0002] As we all know, hyperosteogeny is a disease with pathological hyperplasia of bone leading to local joint, muscle, and ligament movement disorders, accompanied by pain as the main symptom. It can occur in the cervical spine, lumbar spine, joints, and calcaneus, including hypertrophic spondylitis, hypertrophic osteoarthritis, and calcaneus spurs. Primary disease occurs in the middle-aged and elderly people over 40 years old and the staff who are engaged in load-bearing, standing for a long time, and sitting for a long time, and the pathological changes of the joints and the spine with a large range of motion are more common. The etiology of hyperosteogeny is unknown so far, and most of them belong to the category of senile degenerative diseases. There are many hypotheses about its etiology and p...

AI Technical Summary

Problems solved by technology

At present, Western medicine uses non-hormonal anti-inflammatory and analgesic drugs, physical therapy and surgical treatment, which have a certain effect on relieving symptoms, but so far there is no special effective treatment